C2SPARC: Implementing mobile, POC COVID-19 testing in partnership with a community-based organization to reach women who use drugs.
Project Number3R01DA041243-05S3
Former Number5R01DA041243-05
Contact PI/Project LeaderSHERMAN, SUSAN G.
Awardee OrganizationJOHNS HOPKINS UNIVERSITY
Description
Abstract Text
Project Summary
Marginalized populations such as women who use drugs (WWUD) have elevated risk of COVID-19
with risk mitigation techniques owing to the social nature of drug use procurement, drug use and sex work.
High rates of structural vulnerabilities (e.g., homelessness, hunger, incarceration) in combination with low
levels of healthcare utilization are key drivers of this high burden of disease. Through the “C2SPARC”
study, we propose expanding the depth of our understanding of drivers of POCT uptake in both research
and service delivery contexts. Specifically, we propose adding a 6-month follow-up visit (“C2SPARC visit”)
to the CARE study to more robustly examine trends in POCT uptake over time. Secondly, in partnership
with a leading harm reduction organization that serves WWUD, we propose designing and implementing
POCT on their nighttime mobile outreach van that provides harm reduction (e.g., condoms, naloxone,
syringes) and basic necessities (e.g., food, clothing). C2SPARC will employ Andersen’s Behavioral Model
(Aim 1), PRISM (Practical, Robust, Implementation, and Sustainability Model) (Aim 2), and the Theoretical
Framework of Acceptability (TFA) (Aim 3) to meet the following aims: 1) to examine predisposing (e.g.,
social - homelessness, food insecurity; individual - drug use, race/ ethnicity, health beliefs) factors as well
as enabling (past COVID-19 testing, vaccine uptake) factors that predict uptake of POCT over a six-month
period among WWUD (N=250) in Baltimore, Maryland; 2) to collaborate with the SPARC Center to develop
and implement POCT on their mobile outreach van that primarily serves WWUD in Baltimore City,
Maryland; and to examine the feasibility (e.g., testing uptake) and acceptability (e.g., participant burden,
testing self-efficacy) of mobile POCT testing among WWUD (N=250) who are clients of SPARC outreach.
C2SPARC is innovative its leverage of the Phase I cohort to evaluate POCT testing uptake longitudinally
which will inform the implementation of COVID-testing in the context of a meaningful community
partnership. Situating COVID testing in the context of trusted service provider is urgency needed. The
study’s impact and sustainability will also be enhanced by a community advisory board (CAB). Study results
can be quickly disseminated to policy makers and the target population through products (i.e., fact sheets,
manuscripts) and events (i.e., community forums) to inform community-based testing and eventual
vaccination programs targeting WWUD and similarly marginalized populations.
Public Health Relevance Statement
Project Narrative
The proposed C2SPARC study will examine predisposing and enabling predictors of uptake of point-of-care
COVID-19 testing among a cohort of women who use drugs (N=250) in Baltimore, MD over six months. The 6-
month study visit will be added our Phase I data collection among the cohort which is comprised of a baseline
and 3-month follow-up visit. The addition of the 6-month visit will allow for robust longitudinal data analyses.
Further, we will implement POCT on a nighttime mobile outreach program targeting WWUD, run by our
community partner, the SPARC Center. The feasibility and acceptability of implementing POC will be
measured through secondary data and an anonymous survey with SPARC clients (N=200). Partnership with
SPARC will enhance the intervention’s relevance and sustainability and pave the way for rapid vaccine
distribution to this and other high risk populations.
NIH Spending Category
No NIH Spending Category available.
Project Terms
African AmericanBaltimoreBehaviorBehavioralBehavioral ModelCOVID testingCOVID-19COVID-19 testingCOVID-19 vaccinationChronic DiseaseCitiesClientClothingCommunicable DiseasesCommunitiesComplexCounselingDataData AnalysesData CollectionDrug usageEnabling FactorsEthnic OriginEventFoodHIV/STDHandwashingHarm ReductionHealth PersonnelHomelessnessHungerImmunization ProgramsImprisonmentIndividualInfrastructureInterventionInterviewLengthLettersLung diseasesManuscriptsMarylandMeasuresMedicalNaloxoneNatureParticipantPharmaceutical PreparationsPhasePolicy MakerPractical, Robust Implementation and Sustainability ModelPredictive FactorRADx Underserved PopulationsRaceResearchResearch InfrastructureRiskRunningSeasonsSelf EfficacySocial DistanceStructureSurveysSyringesTarget PopulationsTechniquesTestingTimeTraumaTrustVaccinesVisitWomanWorkacceptability and feasibilityadverse outcomebaseburden of illnesscohortcommunity partnershipcondomscoronavirus diseasedesignexperiencefemale sex workerfollow-upfood insecurityhealth beliefhealth care service utilizationhigh risk populationimplementation processinformantinnovationmarginalized populationoutreachoutreach programpandemic diseasephase 1 studypoint of careprogramsreuptakerisk mitigationservice deliveryservice providerssexsexual violencesocialsocial stigmastudy populationtesting servicestesting uptaketherapy designtrenduptakevaccine acceptancevaccine distribution
No Sub Projects information available for 3R01DA041243-05S3
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 3R01DA041243-05S3
Patents
No Patents information available for 3R01DA041243-05S3
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 3R01DA041243-05S3
Clinical Studies
No Clinical Studies information available for 3R01DA041243-05S3
News and More
Related News Releases
No news release information available for 3R01DA041243-05S3
History
No Historical information available for 3R01DA041243-05S3
Similar Projects
No Similar Projects information available for 3R01DA041243-05S3